<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02573545</url>
  </required_header>
  <id_info>
    <org_study_id>5261</org_study_id>
    <nct_id>NCT02573545</nct_id>
  </id_info>
  <brief_title>Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case</brief_title>
  <acronym>IFE</acronym>
  <official_title>Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate that the use of Standard @IFE and Planning@IFE features of the IFE software,
      compared to the current method, when planning and inserting the needle under MRI monitoring
      in the context of liver biopsies enable:

        -  a facilitation of the planning stages of the procedure (route path, marking of the entry
           point and alignment of the MRI cutaways on the planned path), resulting in a reduction
           in the duration of the planning stages,

        -  a facilitation of the real-time modification of MRI cutaways during the procedure,
           resulting in a reduction of the duration of the procedure
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty recruiting patients
  </why_stopped>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total duration of the intervention (planning and implementation)</measure>
    <time_frame>up to 2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">148</enrollment>
  <condition>Liver Biopsy</condition>
  <arm_group>
    <arm_group_label>Test group: with IFE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients treated with IFE software</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test group: without IFE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with Numaris 4 software</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Planning@IFE and Standard@IFE Software</intervention_name>
    <arm_group_label>Test group: with IFE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MR Syngo (Numaris/4) software</intervention_name>
    <arm_group_label>Test group: without IFE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is at least 18 years old

          -  Affiliated to a social security scheme

          -  Informed consent

          -  Patient with an indication of liver biopsy eligible for a biopsy under interventional
             MRI

        Exclusion Criteria:

          -  Patient with a contraindication for MRI exam

          -  Patient with a contraindication for performing a biopsy

          -  Pregnancy

          -  Exclusion period

          -  Patient unable to receive and understand information about the study

          -  Patients under guardianship

          -  Patients under judicial protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nouvel HÃ´pital civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <study_first_submitted>October 1, 2015</study_first_submitted>
  <study_first_submitted_qc>October 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2015</study_first_posted>
  <last_update_submitted>December 2, 2019</last_update_submitted>
  <last_update_submitted_qc>December 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

